Latest filing published 16 Oct 2026 for Akari Therapeutics Plc, €118k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Hoyoung Huh: trading record in brief
Hoyoung Huh has filed trades across 6 companies (mainly through SEC (Form 4)), most often in Peak Bio, Inc., Geron Corp and Akari Therapeutics PLC. Between 5 September 2009 and 5 October 2026, the trades on record add up to 58 filings.
No open-market sale appears; the market trades are 22 purchases worth €22k. No amount is published for 15 filings, which the totals therefore leave out. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 25 share grants.
A typical purchase (the median) is worth €1,265. No cluster: in 12 purchases, no other insider of the company bought within 30 days.
The newest entry dates from 16 October 2026: a share grant of €118k, in Akari Therapeutics PLC. The last purchase on record was published on 25 September 2023, which is 1,140 days ago. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Hoyoung Huh
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 17,249 shares@ US$7.8990.73% mcap10.8% of flowAmerican Depositary Shares representing Ordinary SharesSEC:0001493152-26-047457:0
- 6,160 shares@ US$7.8990.27% mcap4.0% of flowAmerican Depositary Shares representing Ordinary SharesSEC:0001493152-26-047457:1
- 892,857 shares@ US$1.12100.0% of flowAmerican Depositary Shares representing Ordinary SharesSEC:0000950170-25-036488:0
- 4,574,661 sharesCommon StockSEC:0000950170-24-128149:1
- 8,382,742 sharesCommon StockSEC:0000950170-24-128149:2
- 372,940 sharesCommon StockSEC:0000950170-24-128149:3
- 4,574,661 sharesCommon StockSEC:0000950170-24-128149:0
- 45,000 sharesCommon StockSEC:0000950170-23-049688:0Canonical exit: 20 Dec 2023 (T+90)
- 30,000 sharesCommon StockSEC:0000950170-23-049173:1Canonical exit: 19 Dec 2023 (T+90)
- 50,000 sharesCommon StockSEC:0000950170-23-049173:0Canonical exit: 18 Dec 2023 (T+90)
- 25,000 sharesCommon StockSEC:0000950170-23-048771:0Canonical exit: 14 Dec 2023 (T+90)
- 20,000 sharesCommon StockSEC:0000950170-23-048367:1Canonical exit: 13 Dec 2023 (T+90)
- 30,000 sharesCommon StockSEC:0000950170-23-048367:0Canonical exit: 12 Dec 2023 (T+90)
- 17,000 sharesCommon StockSEC:0000950170-23-047919:1Canonical exit: 11 Dec 2023 (T+90)
- 30,000 sharesCommon StockSEC:0000950170-23-047919:0Canonical exit: 10 Dec 2023 (T+90)
- 00Common StockSEC:0000950170-23-047707:1Canonical exit: 28 Nov 2023 (T+90)
- 00Common StockSEC:0000950170-23-047707:2Canonical exit: 28 Nov 2023 (T+90)
- 00Common StockSEC:0000950170-23-047707:3Canonical exit: 28 Nov 2023 (T+90)
- 00Common StockSEC:0000950170-23-047707:4Canonical exit: 28 Nov 2023 (T+90)
- 00Common StockSEC:0000950170-23-047707:5Canonical exit: 28 Nov 2023 (T+90)
- 00Common StockSEC:0000950170-23-047707:6Canonical exit: 29 Nov 2023 (T+90)
- 00Common StockSEC:0000950170-23-047707:0Canonical exit: 27 Nov 2023 (T+90)
- 1,000 shares@ US$0.2530.0% of flowCommon StockSEC:0000950170-23-046053:1Canonical exit: 28 Nov 2023 (T+90)
- 2,500 shares@ US$0.260.1% of flowCommon StockSEC:0000950170-23-046053:2Canonical exit: 28 Nov 2023 (T+90)
- 3,750 shares@ US$0.2510.1% of flowCommon StockSEC:0000950170-23-046053:3Canonical exit: 28 Nov 2023 (T+90)
25 of 58 declarations
